These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Differential proteomic analysis of virus-enriched fractions obtained from plasma pools of patients with dengue fever or severe dengue. Fragnoud R; Flamand M; Reynier F; Buchy P; Duong V; Pachot A; Paranhos-Baccala G; Bedin F BMC Infect Dis; 2015 Nov; 15():518. PubMed ID: 26572220 [TBL] [Abstract][Full Text] [Related]
5. Experimental in vitro and in vivo systems for studying the innate immune response during dengue virus infections. Kitab B; Kohara M; Tsukiyama-Kohara K Arch Virol; 2018 Jul; 163(7):1717-1726. PubMed ID: 29520688 [TBL] [Abstract][Full Text] [Related]
6. Severity of Plasma Leakage Is Associated With High Levels of Interferon γ-Inducible Protein 10, Hepatocyte Growth Factor, Matrix Metalloproteinase 2 (MMP-2), and MMP-9 During Dengue Virus Infection. Her Z; Kam YW; Gan VC; Lee B; Thein TL; Tan JJ; ; Lee LK; Fink K; Lye DC; Rénia L; Leo YS; Ng LF J Infect Dis; 2017 Jan; 215(1):42-51. PubMed ID: 28077582 [TBL] [Abstract][Full Text] [Related]
7. Human Dengue antibodies against structural and nonstructural proteins. Valdés K; Alvarez M; Pupo M; Vázquez S; Rodríguez R; Guzmán MG Clin Diagn Lab Immunol; 2000 Sep; 7(5):856-7. PubMed ID: 10973471 [TBL] [Abstract][Full Text] [Related]
8. Correlation of host inflammatory cytokines and immune-related metabolites, but not viral NS1 protein, with disease severity of dengue virus infection. Soe HJ; Manikam R; Raju CS; Khan MA; Sekaran SD PLoS One; 2020; 15(8):e0237141. PubMed ID: 32764789 [TBL] [Abstract][Full Text] [Related]
9. Antibody avidity following secondary dengue virus type 2 infection across a range of disease severity. Lau L; Green AM; Balmaseda A; Harris E J Clin Virol; 2015 Aug; 69():63-7. PubMed ID: 26209381 [TBL] [Abstract][Full Text] [Related]
10. An in-depth analysis of original antigenic sin in dengue virus infection. Midgley CM; Bajwa-Joseph M; Vasanawathana S; Limpitikul W; Wills B; Flanagan A; Waiyaiya E; Tran HB; Cowper AE; Chotiyarnwong P; Grimes JM; Yoksan S; Malasit P; Simmons CP; Mongkolsapaya J; Screaton GR J Virol; 2011 Jan; 85(1):410-21. PubMed ID: 20980526 [TBL] [Abstract][Full Text] [Related]
11. Progress towards understanding the pathogenesis of dengue hemorrhagic fever. Pang X; Zhang R; Cheng G Virol Sin; 2017 Feb; 32(1):16-22. PubMed ID: 27853992 [TBL] [Abstract][Full Text] [Related]
12. Re-evaluation of the pathogenic roles of nonstructural protein 1 and its antibodies during dengue virus infection. Chuang YC; Wang SY; Lin YS; Chen HR; Yeh TM J Biomed Sci; 2013 Jun; 20(1):42. PubMed ID: 23806052 [TBL] [Abstract][Full Text] [Related]
14. Characterization of dengue virus infections in a sample of patients suggests unique clinical, immunological, and virological profiles that impact on the diagnosis of dengue and dengue hemorrhagic fever. Senaratne T; Wimalaratne H; Alahakoon DG; Gunawardane N; Carr J; Noordeen F J Med Virol; 2016 Oct; 88(10):1703-10. PubMed ID: 26990973 [TBL] [Abstract][Full Text] [Related]
16. Changing pattern of dengue virus serotypes circulating during 2008-2012 and reappearance of dengue serotype 3 may cause outbreak in Kolkata, India. Saha K; Ghosh M; Firdaus R; Biswas A; Seth B; Bhattacharya D; Mukherjee K; Sadhukhan PC J Med Virol; 2016 Oct; 88(10):1697-702. PubMed ID: 26991505 [TBL] [Abstract][Full Text] [Related]
18. Unsweetened IgG Is Bad for Dengue Patients. Lok SM Cell Host Microbe; 2017 Mar; 21(3):312-314. PubMed ID: 28279340 [TBL] [Abstract][Full Text] [Related]
19. Change in age pattern of persons with dengue, northeastern Brazil. Cavalcanti LP; Vilar D; Souza-Santos R; Teixeira MG Emerg Infect Dis; 2011 Jan; 17(1):132-4. PubMed ID: 21192876 [No Abstract] [Full Text] [Related]
20. Autoimmune pathogenesis in dengue virus infection. Lin CF; Wan SW; Cheng HJ; Lei HY; Lin YS Viral Immunol; 2006; 19(2):127-32. PubMed ID: 16817755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]